A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR)

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507721-41-00

Acronym

SPI-62-CL-1002

Enrollment

Registered

2024-02-20

Start date

2024-03-11

Completion date

2024-12-03

Last updated

2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polymyalgia rheumatica

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026